References
Sowerwine KJ, Holland SM, Freeman AF. Hyper-IgE syndrome update. Ann N Y Acad Sci. 2012;1250:25–32. https://doi.org/10.1111/j.1749-6632.2011.06387.x.
Mogensen TH. Primary immunodeficiencies with elevated IgE. Int Rev Immunol. 2016;35(1):39–56. https://doi.org/10.3109/08830185.2015.1027820.
Yong PF, Freeman AF, Engelhardt KR, Holland S, Puck JM, Grimbacher B. An update on the hyper-IgE syndromes. Arthritis Res Ther. 2012;14(6):228. https://doi.org/10.1186/ar4069.
Zhang Q, Boisson B, Beziat V, Puel A, Casanova JL. Human hyper-IgE syndrome: singular or plural? Mamm Genome. 2018;29(7–8):603–17. https://doi.org/10.1007/s00335-018-9767-2.
Ma CA, Stinson JR, Zhang Y, Abbott JK, Weinreich MA, Hauk PJ, et al. Germline hypomorphic CARD11 mutations in severe atopic disease. Nat Genet. 2017;49(8):1192–201. https://doi.org/10.1038/ng.3898.
Dadi H, Jones TA, Merico D, Sharfe N, Ovadia A, Schejter Y, et al. Combined immunodeficiency and atopy caused by a dominant negative mutation in caspase activation and recruitment domain family member 11 (CARD11). J Allergy Clin Immunol. 2018;141(5):1818–30 e2.
Schwerd T, Twigg SRF, Aschenbrenner D, Manrique S, Miller KA, Taylor IB, et al. A biallelic mutation in IL6ST encoding the GP130 co-receptor causes immunodeficiency and craniosynostosis. J Exp Med. 2017;214(9):2547–62. https://doi.org/10.1084/jem.20161810.
Shahin T, Aschenbrenner D, Cagdas D, Bal SK, Conde CD, Garncarz W, et al. Selective loss of function variants in IL6ST cause hyper-IgE syndrome with distinct impairments of T-cell phenotype and function. Haematologica. 2019;104(3):609–21. https://doi.org/10.3324/haematol.2018.194233.
Frey-Jakobs S, Hartberger JM, Fliegauf M, Bossen C, Wehmeyer ML, Neubauer JC, et al. ZNF341 controls STAT3 expression and thereby immunocompetence. Sci Immunol. 2018;3:24. https://doi.org/10.1126/sciimmunol.aat4941.
Lee WI, Huang JL, Lin SJ, Yeh KW, Chen LC, Hsieh MY, et al. Clinical aspects and genetic analysis of Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES). J Clin Immunol. 2011;31(2):272–80. https://doi.org/10.1007/s10875-010-9479-1.
Lee WI, Huang JL, Lin SJ, Yeh KW, Chen LC, Ou LS, et al. Clinical, immunological and genetic features in Taiwanese patients with the phenotype of hyper-immunoglobulin E recurrent infection syndromes (HIES). Immunobiology. 2011;216(8):909–17. https://doi.org/10.1016/j.imbio.2011.01.008.
Schimke LF, Sawalle-Belohradsky J, Roesler J, Wollenberg A, Rack A, Borte M, et al. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol. 2010;126(3):611–7 e1. https://doi.org/10.1016/j.jaci.2010.06.029.
Wu J, Chen J, Tian ZQ, Zhang H, Gong RL, Chen TX, et al. Clinical manifestations and genetic analysis of 17 patients with autosomal dominant hyper-IgE syndrome in mainland China: new reports and a literature review. J Clin Immunol. 2017;37(2):166–79. https://doi.org/10.1007/s10875-017-0369-7.
Woellner C, Gertz EM, Schaffer AA, Lagos M, Perro M, Glocker EO, et al. Mutations in STAT3 and diagnostic guidelines for hyper-IgE syndrome. J Allergy Clin Immunol. 2010;125(2):424–32 e8. https://doi.org/10.1016/j.jaci.2009.10.059.
Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, et al. Hyper-IgE syndrome with recurrent infections--an autosomal dominant multisystem disorder. N Engl J Med. 1999;340(9):692–702. https://doi.org/10.1056/NEJM199903043400904.
Donabedian H, Gallin JI. The hyperimmunoglobulin E recurrent-infection (Job’s) syndrome. A review of the NIH experience and the literature. Medicine (Baltimore). 1983;62(4):195–208. https://doi.org/10.1097/00005792-198307000-00001.
Bocchini CE, Nahmod K, Katsonis P, Kim S, Kasembeli MM, Freeman A, et al. Protein stabilization improves STAT3 function in autosomal dominant hyper-IgE syndrome. Blood. 2016;128(26):3061–72. https://doi.org/10.1182/blood-2016-02-702373.
Acknowledgments
We wish to thank the patients for participating in this study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
All patients provided consent to participate in the study.
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(DOCX 13 kb)
Rights and permissions
About this article
Cite this article
Larsen, C.S., Christiansen, M. & Mogensen, T.H. Autosomal Dominant Hyper-IgE Syndrome Without Significantly Elevated IgE. J Clin Immunol 39, 827–831 (2019). https://doi.org/10.1007/s10875-019-00683-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10875-019-00683-8